CTOs on the Move

Vascular Therapies

www.vasculartx.com

 
Vascular Therapies, Inc., a privately-held late-stage biopharmaceutical company, is developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Vascular Therapies raised $17.3M on 01/29/2020
Vascular Therapies raised $23.9M on 03/04/2022

Similar Companies

Intellipharmaceutics

We believe that our Hypermatrix technology is a novel and robust controlled-release drug delivery platform. This unique technology allows us to provide life-cycle management or new chemical entity delivery system solutions for virtually any small molecule. The flexibility of this technology allows us to quickly develop complex drug delivery solutions.

Sollis Therapeutics

Sollis Therapeutics is a privately held pharmaceutical company developing non-opioid analgesic products. Our first product is a long acting formulation of a compound with both analgesic and anti-inflammatory properties this combination is perfectly tailored to the treatment of severe neuropathic pain conditions such as sciatica.

Beech Brook

Helping children & families thrive by promoting healthy child development, strengthening the ability to overcome adversity, & enhancing family health & stability.

Reliance Health

Reliance Health is a non-profit community mental health center focused on enhancing health through mental wellness.

Envision Communications

Envision Communications is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.